Shield Therapeutics is a specialty pharmaceutical company focused on the development and commercialisation of late‑stage, hospital‑focused pharmaceuticals which address areas of unmet medical need.
Find out moreOur lead product, Feraccru®, is a novel oral ferric iron therapy that is approved and marketed in the European Union for the treatment of Iron Deficiency (ID) with or without anaemia in adults and in Switzerland for the treatment of Iron Deficiency Anaemia (IDA) in adults with inflammatory bowel disease (IBD).
Find out moreICYMI Our latest podcast is on the #STX website. Listen to Dr Jackie Mitchell our VP Regulatory Affairs and Quality… https://t.co/ohjbz07r5R
We are looking forward to attending @EuroMed_Awards in London tomorrow evening. Good luck to all those shortlisted… https://t.co/7URCTknGIg
RT @VoxPodcast: #STX @ShieldTx was 1 of the most followed companies on @VOXmarkets in the last 24 hrs. See the top 10 lists here> https://…
